etidronate has been researched along with calcitriol in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (26.67) | 18.7374 |
| 1990's | 17 (37.78) | 18.2507 |
| 2000's | 13 (28.89) | 29.6817 |
| 2010's | 2 (4.44) | 24.3611 |
| 2020's | 1 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sambrook, P | 2 |
| Devlin, RD; Gutteridge, DH; Prince, RL; Retallack, RW; Worth, GK | 1 |
| Binswanger, U; Jungbluth, H | 1 |
| Dandona, P; Khokher, MA | 1 |
| Wada, F | 1 |
| Clemens, TL; Gordon, AC; Gundberg, CM; Jacobs, TP; Reich, L; Shane, E; Silverberg, SJ | 1 |
| Edelstein, S; Lidor, C; Meyer, MS; Wasserman, RH | 1 |
| Eguchi, M; Kawamura, H; Shibata, K; Shimauchi, T; Shiota, E; Sugioka, Y; Wada, F | 1 |
| Binswanger, U; Peters, J | 1 |
| Boyce, BF; Boyle, IT; Cowan, RA; Fogelman, I; Jenkins, A; Ralston, SH; Smith, ML | 1 |
| Itokawa, Y; Kawamura, J; Nonomura, M; Okada, Y; Takashima, M; Yoshida, O | 1 |
| Bonjour, JP; Eisman, JA; Fleisch, H; Taylor, CM; Trechsel, U | 1 |
| Feely, J; Paterson, CR | 1 |
| Norman, DA; Pak, CY; Zerwekh, JE | 1 |
| Heath, H; Odell, WD | 1 |
| Feldmeier, H; Karbach, U | 1 |
| Barbier, A; Murakami, H; Nakamura, I; Sasaki, T; Suda, T; Takahashi, N; Tanaka, S; Udagawa, N; Zhang, D | 1 |
| Bass, S; Pearce, G; Seeman, E; Tsalamandris, C | 1 |
| Sambrook, PN | 1 |
| Boyce, RW; Eriksen, EF; Franks, AF; Jankowsky, ML; Paddock, CL | 1 |
| Bayraktar, M; Gedik, O; Gürlek, A | 1 |
| Arnala, I; Heikkinen, JE; Laitinen, K; Selander, KS; Väänänen, HK | 1 |
| Androulakis, C; Galanos, A; Lyritis, GP; Paspati, I; Skarantavos, G; Tsakalakos, N | 1 |
| Funaba, Y; Kawabe, N; Nakadate-Matsushita, T; Tanahashi, M; Tateishi, A | 1 |
| Bohnensack, R; Geurtsen, W; Leyhausen, G; Lorenz, B; Müller, WE; Schröder, HC; Zhu, H | 1 |
| Bekker, PJ; Clemens, TL; Eusebio, RA; Singer, FR | 1 |
| Donnelly, S; Doyle, DV; Keen, RW; Masud, T; Mulcahy, B; Spector, TD; Thompson, AV | 1 |
| Addesso, V; Lo, SH; Mancini, D; McMahon, DJ; Michler, RE; Rodino, MA; Seibel, MJ; Shane, E; Staron, RB | 1 |
| Eisman, JA; Sambrook, PN | 1 |
| Compston, JE | 1 |
| Asoh, T; Kaji, M; Oizumi, K; Sato, Y | 1 |
| Blackwell, PJ; Cawte, SA; Fowler, I; Hosking, DJ; Lawson, N; Masud, T; Sahota, O; San, P | 1 |
| Eisman, J; Glanville, A; Henderson, K; Keogh, A; MacDonald, P; Sambrook, P; Spratt, P | 1 |
| Catanzariti, L; Cortet, B; Delcambre, B; Grardel, B; Marchandise, X; Vasseur, J | 1 |
| Erben, RG; Leyshon, A; Mosekilde, L; Phipps, R; Smith, SY; Stahr, K; Thomsen, JS; Weber, K | 1 |
| Arsura, EL; Caldwell, JW; Johnson, RH; Kilgore, WB; Reddy, CM | 1 |
| Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R | 1 |
| Aizawa, S; Hashiba, H; Kogo, H; Suzuki, Y; Tamura, H; Tamura, K | 1 |
| Iwamoto, J; Sato, Y; Seki, A; Shen, CL; Takeda, T; Yamada, H; Yeh, JK | 2 |
| Casado-Díaz, A; Dorado, G; Navarro-Valverde, C; Quesada-Gómez, JM; Santiago-Mora, R | 1 |
| Hatano, M; Hirota, Y; Hoshino, J; Isawa, K; Kitajima, I; Nakamura, M; Sawa, N; Ubara, Y; Yamamoto, S | 1 |
7 review(s) available for etidronate and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcitriol and postmenopausal osteoporosis.
Topics: Anabolic Agents; Bone Density; Calcitriol; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride | 1992 |
Corticosteroid-induced osteoporosis.
Topics: Bone Density; Calcitonin; Calcitriol; Calcium; Etidronic Acid; Humans; Osteoporosis; Prednisone; Randomized Controlled Trials as Topic | 1994 |
Osteoporosis: pathophysiology, prevention, diagnosis, and treatment.
Topics: Bone Density; Calcitriol; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic Acid; Exercise; Female; Humans; Male; Osteoporosis | 1993 |
Present and future of osteoporosis therapy.
Topics: Bone Density; Bone Development; Bone Resorption; Calcitonin; Calcitriol; Calcium, Dietary; Diphosphonates; Drug Delivery Systems; Estrogens; Etidronic Acid; Female; Fluorides; Fractures, Spontaneous; Hip Fractures; Humans; Male; Osteoporosis; Parathyroid Hormone; Spinal Fractures; Structure-Activity Relationship | 1995 |
Osteoporosis prevention and treatment.
Topics: Alendronate; Anabolic Agents; Bone Density; Calcitriol; Calcium; Estrogen Replacement Therapy; Etidronic Acid; Evidence-Based Medicine; Female; Humans; Male; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; Risk Factors; Treatment Outcome; Vitamin D | 2000 |
Stimulation of in-vitro angiogenesis by low concentrations of risedronate is mitigated by 1,25-dihydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Bone Density Conservation Agents; Calcitriol; Etidronic Acid; Humans; In Vitro Techniques; Neovascularization, Physiologic; Risedronic Acid | 2015 |
9 trial(s) available for etidronate and calcitriol
| Article | Year |
|---|---|
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Topics: Alkaline Phosphatase; Calcitriol; Creatinine; Double-Blind Method; Etidronic Acid; Humans; Hydroxyproline; Minerals; Osteitis Deformans; Random Allocation | 1987 |
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Analysis of Variance; Biomarkers; Bone Density; Calcitonin; Calcitriol; Drug Synergism; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome; Turkey | 1997 |
Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Clodronic Acid; Collagen; Collagen Type I; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Femur Neck; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Procollagen; Prospective Studies | 1997 |
The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: a four-year study.
Topics: Aged; Bone Density; Calcitriol; Cohort Studies; Etidronic Acid; Female; Femoral Neck Fractures; Humans; Osteoporosis, Postmenopausal; Prospective Studies; Spinal Fractures | 1997 |
Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Bone Density; Calcitriol; Drug Therapy, Combination; Etidronic Acid; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal | 1998 |
Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
Topics: Absorptiometry, Photon; Aged; Amino Acids; Bone Density; Bone Diseases, Metabolic; Calcium; Collagen; Collagen Type I; Double-Blind Method; Etidronic Acid; Female; Hemiplegia; Humans; Male; Parathyroid Hormone; Peptides; Prospective Studies; Stroke; Vitamin D | 2000 |
A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodeling; Calcitriol; Calcium Channel Agonists; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Radiography; Spinal Diseases | 2000 |
Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation.
Topics: Adrenal Cortex Hormones; Adult; Calcitriol; Calcium; Cyclosporine; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Hydroxyproline; Lung Transplantation; Male; Middle Aged; Osteocalcin; Osteoporosis | 2001 |
Management of male osteoporosis.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Dietary Supplements; Etidronic Acid; Femur Neck; Humans; Hydrochlorothiazide; Hypercalcemia; Hypogonadism; Hypophosphatemia, Familial; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Phosphates; Testosterone; Vitamin D | 2001 |
29 other study(ies) available for etidronate and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
Topics: 24,25-Dihydroxyvitamin D 3; Aged; Alkaline Phosphatase; Calcifediol; Calcitonin; Calcitriol; Calcium; Etidronic Acid; Humans; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Vitamin D | 1990 |
Unidirectional duodenal and jejunal calcium and phosphorus transport in the rat: effects of dietary phosphorus depletion, ethane-1-hydroxy-1,1-diphosphonate and 1,25 dihydroxycholecalciferol.
Topics: Animals; Biological Transport, Active; Calcitriol; Calcium; Diet; Duodenum; Etidronic Acid; Intestinal Mucosa; Jejunum; Male; Phosphorus; Rats; Rats, Inbred Strains | 1989 |
Diphosphonates inhibit human osteoblast secretion and proliferation.
Topics: Alkaline Phosphatase; Calcitriol; Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Kinetics; Osteoblasts; Pamidronate; Thymidine | 1989 |
[Calcification-promoting action of vitamin D metabolites on the growth plate cartilage of rats with 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP)-induced rickets].
Topics: Animals; Calcification, Physiologic; Calcitriol; Cartilage; Cholecalciferol; Dihydroxycholecalciferols; Diphosphonates; Etidronic Acid; Female; Growth Plate; Hydroxycholecalciferols; Rats; Rats, Inbred Strains; Rickets | 1987 |
Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
Topics: Adult; Aged; Aged, 80 and over; Calcifediol; Calcitriol; Calcium; Creatinine; Cyclic AMP; Etidronic Acid; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Male; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone; Phosphorus | 1987 |
The effect of disodium ethane-1-hydroxy-1,1-diphosphonate on the metabolism of calcitriol in chicks.
Topics: Animals; Bile; Calcitriol; Calcium; Chickens; Duodenum; Etidronic Acid; Intestinal Absorption; Phosphates; Receptors, Calcitriol; Receptors, Steroid; S100 Calcium Binding Protein G | 1987 |
A comparative study of the calcification-promoting action of 1,25 (OH)2D3 and calcitonin on the growth cartilage of rats with 1-hydroxyethylidene-1, 1-biphosphonic acid (HEBP)-induced rickets.
Topics: Alkaline Phosphatase; Animals; Calcification, Physiologic; Calcitonin; Calcitriol; Calcium; Etidronic Acid; Female; Growth Plate; Phosphorus; Radiography; Rats; Rats, Inbred F344; Rickets | 1987 |
Calcium and inorganic phosphate secretion of rat ileum in vitro. Influence of uremia and 1,25 (OH)2D3 inhibition.
Topics: Animals; Calcitriol; Calcium; Etidronic Acid; Growth Plate; Ileum; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Kinetics; Male; Nephrectomy; Phosphates; Rats; Rats, Inbred Strains; Uremia | 1988 |
[Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Topics: Animals; Blood Urea Nitrogen; Calcitriol; Calcium; Calcium Oxalate; Ethylene Glycols; Etidronic Acid; Kidney Calculi; Magnesium; Male; Oxalates; Oxalic Acid; Phosphates; Rats; Rats, Inbred Strains | 1985 |
Plasma levels of vitamin D metabolites in diphosphonate-treated rats.
Topics: 25-Hydroxyvitamin D 2; Animals; Calcitriol; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, Drug; Ergocalciferols; Etidronic Acid; Male; Phosphorus; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.
Topics: Acromegaly; Bromocriptine; Calcitriol; Danazol; Endometriosis; Etidronic Acid; Female; Fibrocystic Breast Disease; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Kidney Failure, Chronic; Lactation; Menorrhagia; Osteomalacia; Parkinson Disease; Pregnadienes; Pregnancy; Prolactin; Rickets; Vitamin D | 1983 |
An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
Topics: Aged; Alkaline Phosphatase; Calcitriol; Calcium; Dihydroxycholecalciferols; Etidronic Acid; Female; Humans; Hydroxyproline; Intestinal Absorption; Male; Middle Aged; Osteitis Deformans; Phosphorus | 1981 |
The cecum is the site with the highest calcium absorption in rat intestine.
Topics: Animals; Biological Transport, Active; Calcitriol; Calcium; Cecum; Dexamethasone; Etidronic Acid; Intestinal Absorption; Intestinal Mucosa; Magnesium; Rats; Rats, Wistar | 1993 |
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Resorption; Calcitriol; Cell Polarity; Cells, Cultured; Collagen; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Giant Cells; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Osteoblasts; Osteoclasts | 1995 |
Calcium and vitamin D therapy in corticosteroid bone loss: what is the evidence.
Topics: Adrenal Cortex Hormones; Calcitonin; Calcitriol; Calcium; Etidronic Acid; Humans; Osteoporosis; Vitamin D | 1996 |
Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Topics: Animals; Bone and Bones; Bone Remodeling; Calcitriol; Calcium; Calcium Channel Blockers; Dogs; Drug Therapy, Combination; Etidronic Acid; Humans; Risedronic Acid; Teriparatide | 1996 |
TRK-530 inhibits accumulation of superoxide anions derived from human polymorphonuclear leukocytes and bone resorption induced by activated osteoclasts.
Topics: Animals; Animals, Suckling; Antioxidants; Bone Resorption; Calcitriol; Calcium Channel Blockers; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Hindlimb; Humans; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Osteoclasts; Risedronic Acid; Superoxides | 1998 |
Inorganic polyphosphate in human osteoblast-like cells.
Topics: Acid Anhydride Hydrolases; Alkaline Phosphatase; Animals; Calcitriol; Cell Differentiation; Cell Division; Cells, Cultured; Dexamethasone; Diphosphonates; Epidermal Growth Factor; Etidronic Acid; Glycerophosphates; HL-60 Cells; Humans; Inorganic Pyrophosphatase; Mandible; Osteoblasts; Polyphosphates; Pyrophosphatases; Rats; Solubility | 1998 |
Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitriol; Calcium; Calcium Channel Blockers; Creatinine; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus; Risedronic Acid | 1998 |
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Topics: Absorptiometry, Photon; Amino Acids; Biomarkers; Bone Density; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Hormone; Pilot Projects; Vitamin D | 1998 |
Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Topics: Aged; Alendronate; Calcitriol; Calcium Channel Agonists; Calcium Channel Blockers; Estrogen Antagonists; Etidronic Acid; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risedronic Acid; Spinal Fractures | 2000 |
Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Calcitriol; Etidronic Acid; Female; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2002 |
Hypercalcemia in patients with disseminated coccidioidomycosis.
Topics: Adult; Aged; Calcium; Coccidioidomycosis; Diphosphonates; Etidronic Acid; Female; Humans; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Retrospective Studies; Vitamin D | 2004 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome | 2004 |
Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy.
Topics: Amino Acids; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Body Weight; Bone and Bones; Bone Density; Calcinosis; Calcitriol; Calcium Channel Agonists; Creatinine; Disease Models, Animal; Drug Interactions; Etidronic Acid; Male; Nephrectomy; Osteocalcin; Rats; Rats, Wistar; Renal Insufficiency; Time Factors | 2005 |
Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Calcitriol; Calcium; Etidronic Acid; Female; Femur; Phosphorus; Rats; Rats, Sprague-Dawley; Risedronic Acid; Tibia; Tomography, X-Ray Computed | 2006 |
Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Etidronic Acid; Female; Glucocorticoids; Methylprednisolone; Osteogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2006 |
Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
Topics: Bone and Bones; Bone Density Conservation Agents; Calcitriol; Cholecalciferol; Etidronic Acid; Humans; Ilium; Male; Middle Aged; Osteitis Fibrosa Cystica; Osteomalacia; Renal Dialysis; Vitamin D Deficiency | 2021 |